News

Aprazer Healthcare Launched Dasakast

Launch Date: 03-06-2020

Aprazer Healthcare Launched DASAKAST (Dasatinib ) which is a medication used to treat newly diagnosed adults Philadelphia Chromosome -Positive( Ph+ ) Chronic Myeloid Leukemia in Chronic Phase, Advanced Chronic Leukemia & Acute Lymphoblastic Leukemia.